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Abstract
Background: Adult vaccination status may be difficult to obtain, often requiring providers to rely
on individual patient recall. To determine vaccination status awareness and the sociodemographic
predictors of awareness for tetanus, hepatitis A and B, tick born encephalitis (TBE) and influenza
vaccination.
Methods: Multivariate analyses were used to evaluate a questionnaire survey of 10 321 employees
(4070 women and 6251 men aged 15–72 years) of two companies in Switzerland.
Results: Among 10 321 respondents, 75.5% reported knowing their tetanus vaccination status,
64.1% hepatitis A, 61.1% hepatitis B, 64.3% TBE and 71.9% influenza. Between 1 in 4 and 1 in 3
employees were not aware of their vaccination status. Differences in awareness for the five
vaccinations considered correlated with gender and language. These differences persisted in
multivariate analyses.
Conclusion: Women employees, German-speaking employees and employees who paid more
attention to their diet were more often aware of their vaccination status. A more reliable and
readily accessible data source for vaccination status is needed in order to capitalize on
opportunities to update vaccinations among Swiss employees.
Background
Thanks to efficacious vaccination campaigns, high hygi-
enic standards and a high standard of living, diseases such
as poliomyelitis, tetanus, diphtheria, pertussis, and con-
genital rubella syndrome are now rare in Switzerland [1].
However, the low incidence of these diseases combined
with concerns over safety of vaccines have created much
controversy [2–9]. The Swiss Federal Office of Public
Health (SFOPH) has launched several public awareness
campaigns in recent years emphasising the importance of
vaccination. Public awareness campaigns are likely to be
particularly effective at increasing vaccination rates
against diseases occurring seasonally, such as influenza or
tick born encephalitis, that require annual vaccination
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campaigns. Vaccines for other diseases, such as hepatitis A
and B or tetanus, are not repeated annually. Therefore,
vaccination status, including completion of a basic series
and last booster dose, can be difficult to obtain. Conse-
quently, health care providers administering vaccinations
where medical records are lacking must rely on individual
patient recall.
Validation studies of self-reported vaccination status
showed that patient self-report was a highly sensitive and
moderately specific measure of vaccination status [10,11].
One study showed that patient self-report of vaccinations
not requiring annual boosters, such as pneumococcal vac-
cination, had lower specificity than that of vaccinations
given annually, such as influenza [11]. More specifically,
the study found that although relatively few false-negative
cases would have been missed through self-report for
both vaccinations (0–2% for influenza vaccination and
3–10% for pneumococcal vaccination, respectively),
depending on the population studied, (i.e. veterans
administration versus managed care organization), false-
positive cases would have been much more frequent. 21–
29% of reported influenza vaccinations and 46–47% of
reported pneumococcal vaccinations would have been
false positive, leading to many missed opportunities to
vaccinate [11].
Because people either misplace or neglect to carry their
vaccination cards with them, and increasing mobility
necessitating periodic changes in health care provider for
vaccinations, reliance on self-report will continue to
occur, unless new strategies, such as national registries,
become standard. But for the time being, such national
registries have been shown to have low acceptance [12].
Many vaccine-preventable diseases occur among adults
and cause mortality in Europe as well as in the US [13–
17]. Vaccination screening and administration at the
workplace have been shown to be an effective way to
deliver comprehensive immunization services to employ-
ees [18].
In order to determine the awareness of vaccination status
among Swiss employees, we analyzed data on immuniza-
tion status from the "Check Bus" Project [19], along with
demographic, psychological and behavioral predictors of
vaccination status awareness.
Review of the studied vaccinations
Tetanus
All men aged 18 to 20 years without a valid tetanus vacci-
nation at the beginning of their compulsory military serv-
ice in Switzerland are inoculated. The tetanus vaccination
was first available in 1938 (Wiedenmann, M., August
2000, Berna, personal communication), and in 1963, the
first written recommendation was made (Roost, H.-P.,
August 2000, SFOPH, personal communication). Cur-
rently, tetanus vaccination is recommended for every
infant, three times in infancy and three times in child-
hood. Subsequent routine doses are administered every
10 years unless an injury necessitates an earlier booster. In
1998, 93.3% of Swiss children had completed the tetanus
immunization series (three doses) [20]. There were, how-
ever, very few tetanus cases registered: between 1 and 5
cases per year from 1988 to 1998 [21], and 4 cases in the
year ending August 22, 2000, annual incidence: 0.06/
100'000 population [22]. By comparison, in 1996 there
were 17 reported cases in Germany, annual incidence:
0.2/1'000'000 population [23] and 8 in the United King-
dom, annual incidence: 0.1/1'000'000 population [3].
Hepatitis B
In 1980, the hepatitis B vaccine was introduced in Switzer-
land for people at high risk, e.g. health care and dentistry
workers, laboratory workers and drug addicts (Wieden-
mann, M., August 2000, Berna). Since 1997 hepatitis B
has been part of the national immunization program for
children between 11 and 15 years of age. Vaccination of
newborns is only recommended for groups at risk, e.g.
babies with HB-antigen positive mothers [24].
Hepatitis A
In 1992, the active hepatitis A vaccine was introduced in
Switzerland. The annual mortality rate for hepatitis A is
very low (0.96/1'000'000 population) [25]. The vaccine is
mostly administered to people travelling to potentially
endemic countries with poor hygiene [26]. Since 1995,
the 250 – 500 new cases of infections per year in Switzer-
land [21] were mostly travellers returning from endemic
areas and drug-addicts [27].
Tick Born Encephalitis (TBE)
TBE is an endemic disease contracted through bites from
infected ticks in well-known areas (mostly in German-
speaking areas of Switzerland). With 68 incident cases in
1998, 112 cases in 1999, 93 cases for 2000 and 107 cases
in 2001 [28,29] and an average overall incidence of 0.46/
1'000'000 population per year, it is a rather rare, but
present disease [30]. An active vaccine has been commer-
cially available since 1979 [31]. This vaccine, which is
administered as a three dose regimen, is mainly given to
people at high risk, i.e. people who regularly spend time
in forests in an endemic area, be it for work, or leisure
[30].
Influenza
According to Swiss vaccine recommendations, [32] influ-
enza vaccinations should be performed annually between
mid-October and mid-November. The vaccine remains
effective for 4–6 months [32]. Current SwissBMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/18
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recommendations for influenza vaccination (2001/2002)
include persons older than 65, children and adults with
chronic conditions such as heart or lung diseases, as well
as those who need regular medical treatment or hospital-
izations [33]. For these high-risk groups, the costs are
borne by health insurance. While for others, who are also
at increased risk or who may risk transmitting the influ-
enza virus to individuals at high risk, such as clinical staff
personnel and close contacts of individuals at high risk,
insurance has no obligation to bear the costs [33]. Case-
fatality rates for influenza begin to rise at the age of 45
years and are highest in people with multiple chronic
medical conditions [34].
The annual national vaccination campaigns put on by the
Swiss government have not been as successful as some
had hoped. In 1996, only 3.3% of all employees had been
vaccinated. In that same year, the overall vaccination rate
of the Swiss population, using units of sold vaccines, was
estimated to be around 6%. It increased to approximately
14% in 2000 [35]. This vaccination rate is comparable
with other European countries. Spain, France, the Nether-
lands and Italy reached immunization rates of more than
15% in 1997, while Germany, Great Britain and Belgium
have rates ranging from 10–15% [35,36].
Methods
The national information and prevention campaign
"Check Bus", which took place from August 1996 to
August 1998, invited all employees of two nationwide
companies (a large Swiss bank and an industrial com-
pany) to participate. Participants completed a self-admin-
istered questionnaire containing, among others,
questions concerning their vaccination status. The ques-
tionnaire was available in the three Swiss national lan-
guages: German, French and Italian. Participants were
asked to present their vaccination certificates. Methods
have been described in detail elsewhere [19].
We assessed the status of the following vaccinations: teta-
nus, hepatitis A and B, tick-borne encephalitis (TBE) and
influenza. Influenza vaccination rates were only analyzed
for the years 1996 and 1997 as the vaccination period
begins in October and the "Check Bus" Project ended in
August 1998.
First, we analyzed the following groups of variables for
statistical significance in bivariate tests using Chi-square
for each vaccine: Demographics (age, gender, marital sta-
tus, language), psychological factors (general well-being,
emotional well-being, stress), and behavioral factors
(medication use, alcohol use, smoking status, physical
activity and dietary attitudes). Age was categorized into
the following groups: -24, 25–34, 35–44, 45–54 and 55+
years. We divided marital status into the categories single,
married, divorced and widowed. Language represented
the language for which the questionnaire was requested
and included German, French and Italian. To assess gen-
eral well-being, the following question was asked: "How
is your current state of health?" The respondents had the
choice among four answers, ranging from "poor" to
"excellent". Emotional well-being was a composite meas-
ure of four questions on feeling down or depressed, calm
and balanced, tense and nervous, and full of energy and
optimism, that evaluated on how many days of the last
week respondents felt that way. The four choices were
almost every day, on 3–4 days, on 1–2 days and never. The
respondents' summary scores were calculated and classi-
fied into four groups: poor, moderate, good, and
excellent.
Stress was assessed by asking six questions on conditions
at work that could be perceived as stressful, such as long
working hours, conflicting private life and work, and work
under time pressure. Answers were given on a six point
Likert scale, summary scores were calculated and follow-
ing groups defined: never, sometimes, frequent, constant.
Medication use assessed the frequency of four common
medications, sleeping pills, painkillers, tranquilizers and
laxatives. The answers on a five point Likert scale were
summed up to a single score and then divided into the
groups never, sometimes, frequently and constantly. Alco-
hol use was largely a measure of frequency and asked the
"usual" consumption of alcoholic beverages per week.
Answers ranged from never / abstinent to 3 times daily or
more often and were categorised into never/seldom, once/
several times a week, once/ several times a day.
Smoking status was divided into current smoker (ever
smoked regularly during more than 6 months and cur-
rently smoking), ex-smoker (ever smoked regularly during
more than 6 months, but not currently smoking) and
non-smoker (never smoked regularly for more than 6
months and not currently smoking). We accepted the pos-
sibility that some of the participants would not fall into
any of the three categories by choosing a relatively long
duration of regular smoking in favour of exclusion of
experimenters and occasional smokers. Like alcohol use,
physical activity assessed mainly the frequency by asking
how many days per week the participant was involved in
any leisure activity through which he or she would sweat
("e.g. brisk walking, running, bicycling, etc."), ranging
from never to 7x per week. Finally, dietary attitude was
assessed by asking about any particular attention partici-
pants paid to twelve components, such as sweets, salt, fat,
alcohol, diversity of food, regular meals, vegetarian diet,
etc. A summary score was calculated from dichotomous
answers on each component and then categorised into
following groups: paid strict attention, paid attention,
paid little attention, paid no attention.BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/18
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Variables with statistically significant differences in bivar-
iate tests (Chi-squared test) at p < 0.05 were entered into
logistic regression models using SPSS 10. A two-tailed sig-
nificance level was set at p < 0.01 for the multivariate tests.
Results
A total of 10 321 (41% of all employees) data sets were
available for analysis. Respondents were 39.4% (n =
4070) female and 60.6% (n = 6251) male, corresponding
with the gender distribution in the participating compa-
nies. Of the participants, 82.3% (n = 8495) were German-
speaking, 13.8% (n = 1419) French-speaking and 3.9% (n
= 407) Italian-speaking. At the time of questioning 83.9%
(n = 8657) worked for the bank and 16.1% (n = 1664) for
the industrial company. Of the participants, 67.2% (n =
6938) were staff, 23.1% (n = 2382) were cadre, 7.4% (n =
767) were supervisors, and 2.3% (n = 234) withheld this
information.
Tetanus
Of the 10 063 participants who answered the questions
on tetanus vaccination (258 or 2.5% did not), 75.5%
(7599) knew their vaccination status (vaccinated 7446 or
74.0%, never vaccinated 153 or 1.5%) and 24.5% (2464)
did not (the difference relative to 100% is due to missing
answers). (Figure 1)
Bivariate analyses (Table 1) showed that age, gender, lan-
guage, marital status, stress at work, emotional well-being,
general well-being, smoking status, alcohol use, dietary
attitude, physical activity (all p < 0.001) and medication
use (p = 0.006) were all associated with awareness of
tetanus vaccination status, while only employment hierar-
chy was not.
In the logistic regression model, four of the significant var-
iables in the bivariate analyses remained independently
associated with awareness of tetanus vaccination status:
age, gender, language and smoking, while marital status,
stress at work, general well-being, emotional well-being,
alcohol use, medication use, dietary attitudes and physical
activity did not.
Hepatitis B
Of the 9427 participants who answered the questions on
hepatitis B vaccination (894 or 8.7% did not), 61.1%
(5757) knew their vaccination status (vaccinated 299 or
3.2%, not vaccinated 5458 or 57.9%), while 38.9%
(3670) did not. Bivariate analyses revealed gender, lan-
guage, smoking status, alcohol use, dietary attitudes (all p
< 0.001), stress (p = 0.003) and emotional well-being (p
= 0.032) to be associated with awareness of hepatitis B
vaccination status, while age, marital status, employment
hierarchy, general well-being, medication use and physi-
cal activity were not.
In the logistic regression model, three variables were inde-
pendently associated with awareness of hepatitis B vacci-
nation status: gender, language and dietary attitudes.
Hepatitis A
Among 9383 respondents who answered the questions on
hepatitis A vaccination (938 or 9.1% did not), 64.1%
(6011) knew their vaccination status (vaccinated 1574 or
16.8%, not vaccinated 4437 or 47.3%), while 35.9%
(3372) did not.
Bivariate analyses showed awareness of hepatitis A vacci-
nation status to be associated with the following variables:
gender, language, stress, smoking status, alcohol use, diet
(all p < 0.001), general well-being (p = 0.002), emotional
well-being (p = 0.028) and marital status (p = 0.017),
while age, employment hierarchy, medication use and
physical activity were not. In the logistic regression model,
four variables were independently associated with aware-
ness of hepatitis A vaccination status: gender, language,
smoking status and dietary attitudes.
Tick-Borne Encephalitis
Among 9520 respondents who answered the questions on
tick-borne encephalitis (801 or 7.8% did not), 64.3%
(6122) knew their vaccination status (vaccinated 224 or
2.4%, not vaccinated 5898 or 62.0%), while 35.7%
(3398) did not.
Table 1: Bivariate Analyses
Age Gender Language Marital
Status
Hierarchy
at Work
Stress at
Work
General
Well-being
Emotional
Well-being
Smoking Alcohol
Use
Medication
Use
Dietary
Attitudes
Physical
Activity
Tetanus <0.001 <0.001 <0.001 <0.001 0.986 <0.001 <0.001 <0.001 <0.001 <0.001 0.006 <0.001 <0.001
Hepatitis B 0.445 <0.001 <0.001 0.376 0.222 0.003 0.058 0.032 <0.001 <0.001 0.725 <0.001 0.294
Hepatitis A 0.128 <0.001 <0.001 0.017 0.528 <0.001 0.002 0.028 <0.001 <0.001 0.745 <0.001 0.115
Tick born 
Encephalitis
0.980 <0.001 <0.001 0.457 0.041 0.002 0.008 0.186 <0.001 <0.001 0.345 <0.001 0.157
Influenza <0.001 <0.001 <0.001 0.529 0.094 0.005 0.092 0.648 <0.001 0.002 0.111 <0.001 0.472
all categorical (Chi-squared test)BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/18
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Bivariate analyses showed awareness of TBE vaccination
status to be associated with the following variables: gen-
der, language, smoking status, alcohol use, diet (all p <
0.001), stress level (0.002), general well-being (0.008)
and employment hierarchy (0.041), while not associated
with age, marital status, emotional well-being, medica-
tion use and physical activity.
In the logistic regression model, five variables were inde-
pendently associated with awareness of TBE vaccination
status: gender, language, employment hierarchy, alcohol
use and dietary attitudes.
Influenza
Among 9679 respondents who answered the questions on
influenza (642 or 6.2% did not), 71.9% (6122) knew
their vaccination status for 1996 and 1997 (vaccinated
308 or 3.2%, not vaccinated 6650 or 68.7%, 1996 vacci-
nated 204 or 2.1%, 1997 vaccinated 104 or 1.1%), while
28.1% (2718) did not.
Bivariate analyses showed awareness of 1996 and 1997
influenza vaccination status to be associated with the fol-
lowing variables: age, gender, language, smoking status,
diet (all p < 0.001), stress (0.005), and alcohol use
(0.002), while marital status, employment hierarchy, gen-
eral well-being, emotional well-being, medication use
and physical activity were not.
In the logistic regression model, six variables were inde-
pendently associated with awareness of influenza vaccina-
tion status in 1996 and 1997: age, gender, language,
stress, smoking status, and dietary attitudes.
Table 2 shows the respondents awareness of vaccination
status (number of individuals with vaccination status
known/unknown) for the characteristic variables together
with the results of the overall logistic regression for each
vaccination.
Discussion
In this working population of two large firms in Switzer-
land, the proportion of known vaccination status (vacci-
nated or not vaccinated) for five different vaccinations
varied between 61.1% for hepatitis B and 75.5% for teta-
nus (Figure 1).
The proportion of employees vaccinated against tetanus
(74.0%) was almost identical with a previous study
among primary care physicians and their employees in
Switzerland, where 74.2% of the medical practice employ-
ees stated to have been vaccinated against tetanus [37].
Figure 1
Participants' awareness of vaccination status for the different vaccinations (υ2 – Test p < 0.001). The 95% CI for each propor-
tion value was below 1%.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Vaccination
missing 2,5 6,2 7,8 9,1 8,7
unknown 24,5 28,1 35,7 35,9 38,9
known 75,5 71,9 64,3 64,1 61,1
Tetanus Influenza Tick born encephalitis Hepatitis A Hepatitis BBMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/18
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Table 2: Logistic Regression
Tetanus Hepatitis B Hepatitis A Tick Born 
Encephalitis
Influenza
n OR (CI) n OR (CI) N OR (CI) N OR (CI) n OR (CI)
Age
-24 807/153 1.0 573/338 - 584/330 - 575/330 - 638/278 1.0
25–34 2520/600 0.84
(0.65, 1.00)
1781/1118 - 1912/986 - 1900/1052 - 2211/772 1.22
(1.04, 1.45)
35–44 2012/619 0.67
(0.53, 0.84)
1496/935 - 1510/869 - 1589/868 - 1859/660 1.24
(1.04, 1.47)
45–54 1647/760 0.48
(0.38, 0.61)
1373/915 - 1438/850 - 1478/828 - 1621/729 0.97
(0.81, 1.15)
55+ 613/332 0.39
(0.30, 0.52)
534/364 - 567/337 - 580/320 - 632/279 0.99
(0.80, 1.23)
Gender
Female 3071/885 1.0 2368/1293 1.0 2510/1177 1.0 2521/1198 1.0 2865/922 1.0
Male 4528/1579 0.84
(0.75, 0.95)
3389/2377 0.79
(0.72, 0.86)
3501/2195 0.77
(0.69, 0.85)
3601/2200 0.7
(0.65, 0.79)
4096/1796 0.73
(0.81, 1.23)
Language
German 6405/1887 1.0 4889/2922 1.0 5048/2706 1.0 5319/2580 1.0 5831/2164 1.0
French 962/411 0.71
(0.62, 0.82)
605/615 0.61
(0.54, 0.69)
698/539 0.72
(0.63, 0.82)
544/679 0.39
(0.34, 0.45)
824/461 0.67
(0.66, 0.81)
Italian 232/166 0.41
(0.32, 0.51)
263/133 1.17
(0.94, 1.46)
265/127 1.15
(0.92, 0.14)
259/139 0.92
(0.74, 1.14)
306/93
Hierarchy at Work
Staff 5099/1663 - 3876/2483 - 4058/2301 - 4088/2338 1.0 4641/1875 -
Superiors 559/180 - 450/254 - 454/234 - 477/226 1.39
(1.16, 1.66)
534/182 -
Cadre 1756/575 - 1300/857 - 1365/769 - 1430/755 1.23
(1.10, 1.37)
1626/610 -
Stress at Work
never 120/73 1.0 88/95 1.0 91/92 1.0 95/87 1.0 115/71 1.0
sometimes 1888/661 1.39
(0.94, 2.06)
1469/909 1.48
(1.05, 2.09)
1535/836 1.56
(1.10, 2.20)
1565/848 1.66
(1.21, 2.28)
1730/715 1.42
(1.04, 1.95)
frequent 5146/1578 1.61
(1.09, 2.37)
3869/2446 1.58
(1.13, 2.21)
4047/2240 1.67
(1.18, 2.34)
2249/4126 1.71
(1.25, 2.28)
4709/1773 1.61
(1.18, 2.20)
constant 445/152 1.70
(1.09, 2.63)
331/220 1.68
(1.15, 2.47)
338/204 1.72
(1.17, 2.54)
336/214 1.70
(1.19, 2.43)
407/159 1.66
(1.16,
Smoking
Non-
Smoker
3981/1103 1.0 3013/1777 1.0 3153/1612 1.0 3186/1632 1.0 3616/1276 1.0
Smoker 2347/884 0.78
(0.69, 0.87)
1755/1250 0.88
(0.80, 0.97)
1822/1172 0.84
(0.76, 0.93)
1864/1180 0.87
(0.79, 0.96)
2124/971 0.80
(0.73, 0.89)
Ex-Smoker 1271/477 0.94
(0.81, 1.08)
989/643 0.93
(0.82, 1.05)
1036/588 0.95
(0.84, 1.08)
1072/586 0.97
(0.86, 1.10)
1221/471 0.98
(0.86, 1.12)
Alcohol Use
never/ 
seldom
2666/813 1.0 2044/1224 1.0 2142/1131 1.0 2143/1156 1.0 2426/912 -
once/ 
several 
times a 
week
4308/1335 1.06
(0.95, 1.19)
2335/2041 1.04
(0.94, 1.14)
3374/1863 1.05
(0.95, 1.15)
3481/1857 1.10
(0.99, 1,21)
3927/1506 -
once/ 
several 
times a day
619/315 0.98
(0.81, 1.18)
472/404 0.84
(0.71, 0.98)
489/377 0.85
(0.72, 1.00)
492/384 0.83
(0.70, 0.98)
602/299 -
Dietary Attitudes
paid strict 
attention
365/115 1.0 298/136 1.0 308/132 1.0 315/129 1.0 359/97 1.0BMC Public Health 2003, 3 http://www.biomedcentral.com/1471-2458/3/18
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The proportion of employees in our study population vac-
cinated against influenza in 1996 or 1997 (3.2%) corre-
sponded with estimates by the Federal Office of Public
Health among employees in 1996 where a vaccination
rate of 3.3% was found. However, this similarity may be
misleading, as a validation study for influenza vaccination
rates has shown that between 20 – 30% of those indicat-
ing to have been vaccinated for Influenza actually had not
been vaccinated, when checked against data in hospital
records [11].
In the bivariate analyses, six independent variables show
a significant association with awareness of vaccination
status for all five immunizations: gender, language, stress,
smoking, alcohol use and dietary behavior.
The results of the logistic regression analyses seem to dis-
criminate mainly between two groups of independent var-
iables. Two variables, gender and language, were
associated with all five types of vaccination, while the rest
of the independent variables were associated with four
(dietary behavior), three (smoking status), two (age) or
one type of vaccination (employment hierarchy and
stress). Interestingly, alcohol use, which was associated
with all five immunizations in bivariate analyses, was
only independently associated with one of the five immu-
nizations in regression analyses.
One important weakness of our study is the lack of data
on non-participants as we were denied access to this infor-
mation. This makes it impossible for us to compare partic-
ipants with non-participants in order to detect any bias
due to differential participation. Details concerning repre-
sentativeness have been discussed in our methods paper
[19].
The Check Bus Project was performed during a period of
major restructuring in one of the two enterprises involved,
which mostly concerned employees in the French-speak-
ing part of Switzerland where the participation rate was
consequently lower. This restructuring could have nega-
tively influenced the participation rate. We did not send
out reminders and the Check Bus visited the different
companies sites only once. In view of this the participa-
tion rate of 41% may be regarded as rather high.
Women, German-speaking people, to a lesser degree peo-
ple who pay more attention to a healthy diet, and the non-
smokers (as compared to the smokers, but not ex-smok-
ers) seem to be more aware of their vaccination status.
Our results show that between 1 in 4 to 1 in 3 of healthy
Swiss employees are unaware of their vaccination status,
even for seasonally recommended vaccines. This indicates
a need for a more reliable and readily accessible, i.e. elec-
tronic, central database where individual vaccination
records are stored. More research into the acceptability of
such a database among the population and health care
providers of Switzerland is also needed.
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